Structure-Based Ligand Design

[1]  Paul R. Gerber,et al.  MAB, a generally applicable molecular force field for structure modelling in medicinal chemistry , 1995, J. Comput. Aided Mol. Des..

[2]  K Gubernator,et al.  Design and synthesis of potent and highly selective thrombin inhibitors. , 1994, Journal of medicinal chemistry.

[3]  B R Schatz,et al.  NCSA Mosaic and the World Wide Web: Global Hypermedia Protocols for the Internet , 1994, Science.

[4]  G. Wider,et al.  Determination of the NMR solution structure of the cyclophilin A-cyclosporin A complex , 1994, Journal of biomolecular NMR.

[5]  T. Blundell,et al.  X-ray analysis at 2.0 A resolution of mouse submaxillary renin complexed with a decapeptide inhibitor CH-66, based on the 4-16 fragment of rat angiotensinogen. , 1994, Journal of molecular biology.

[6]  Paul A. Bartlett,et al.  CAVEAT: A program to facilitate the design of organic molecules , 1994, J. Comput. Aided Mol. Des..

[7]  N. Borkakoti,et al.  Structure of the catalytic domain of human fibroblast collagenase complexed with an inhibitor , 1994, Nature Structural Biology.

[8]  PatrickY.-S. Lam,et al.  Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors. , 1994, Science.

[9]  S. Schreiber,et al.  Crystal structures of cyclophilin A complexed with cyclosporin A and N-methyl-4-[(E)-2-butenyl]-4,4-dimethylthreonine cyclosporin A. , 1994, Structure.

[10]  A. Itai,et al.  Confirmation of usefulness of a structure construction program based on three-dimensional receptor structure for rational lead generation. , 1993, Journal of medicinal chemistry.

[11]  P. Gerber,et al.  The Mechanisms of Action and Inhibition of Pancreatic Lipase and Acetylcholinesterase: A Comparative Modeling Study , 1993 .

[12]  M. Karplus,et al.  Multiple copy simultaneous search and construction of ligands in binding sites: application to inhibitors of HIV-1 aspartic proteinase. , 1993, Journal of medicinal chemistry.

[13]  D. M. Ryan,et al.  Rational design of potent sialidase-based inhibitors of influenza virus replication , 1993, Nature.

[14]  R. Bryan,et al.  The crystal structure of EcoRV endonuclease and of its complexes with cognate and non-cognate DNA fragments. , 1993 .

[15]  I. Kuntz,et al.  Structure-based discovery of inhibitors of thymidylate synthase. , 1993, Science.

[16]  J. Sussman,et al.  Relationship between sequence conservation and three‐dimensional structure in a large family of esterases, lipases, and related proteins , 1993, Protein science : a publication of the Protein Society.

[17]  B. Testa,et al.  Perspectives in Medicinal Chemistry , 1993 .

[18]  R. Huber,et al.  The structure of residues 7-16 of the A alpha-chain of human fibrinogen bound to bovine thrombin at 2.3-A resolution. , 1994, The Journal of biological chemistry.

[19]  Don C. Wiley,et al.  Atomic structure of a human MHC molecule presenting an influenza virus peptide , 1992, Nature.

[20]  Paul R. Gerber,et al.  Peptide mechanics: A force field for peptides and proteins working with entire residues as smallest units , 1992 .

[21]  R. Huber,et al.  Structure of astacin and implications for activation of astacins and zinc-ligation of collagenases , 1992, Nature.

[22]  H Oschkinat,et al.  The interaction of thrombin with fibrinogen. A structural basis for its specificity. , 1992, European journal of biochemistry.

[23]  Hans-Joachim Böhm,et al.  The computer program LUDI: A new method for the de novo design of enzyme inhibitors , 1992, J. Comput. Aided Mol. Des..

[24]  D. Banner,et al.  Crystallographic analysis at 3.0-A resolution of the binding to human thrombin of four active site-directed inhibitors. , 1994, The Journal of biological chemistry.

[25]  W. Howe,et al.  Computer design of bioactive molecules: A method for receptor‐based de novo ligand design , 1991, Proteins.

[26]  S. Harrison,et al.  A structural taxonomy of DNA-binding domains , 1991, Nature.

[27]  A. Goldman,et al.  Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein , 1991, Science.

[28]  F. Winkler,et al.  Refined crystal structure of beta-lactamase from Citrobacter freundii indicates a mechanism for beta-lactam hydrolysis. , 2001, Nature.

[29]  J. Powers,et al.  Reaction of porcine pancreatic elastase with 7-substituted 3-alkoxy-4-chloroisocoumarins: design of potent inhibitors using the crystal structure of the complex formed with 4-chloro-3-ethoxy-7-guanidinoisocoumarin. , 1990, Biochemistry.

[30]  F. Winkler,et al.  Structure of human pancreatic lipase , 1990, Nature.

[31]  J. Frère,et al.  β‐Lactamase of Bacillus licheniformis 749/C at 2 Å resolution , 1990 .

[32]  F. Winkler,et al.  Refined crystal structure of β-lactamase from Citrobacter freundiiindicates a mechanism for β-lactam hydrolysis , 1990, Nature.

[33]  H. Scheraga,et al.  High-resolution NMR studies of fibrinogen-like peptides in solution: interaction of thrombin with residues 1-23 of the A alpha chain of human fibrinogen. , 1989, Biochemistry.

[34]  Klaus Gubernator,et al.  Generic shapes for the conformation analysis of macrocyclic structures , 1988 .

[35]  F. Winkler,et al.  Crystal structure of human dihydrofolate reductase complexed with folate. , 1988, European journal of biochemistry.

[36]  J A McCammon,et al.  Computer-aided molecular design. , 1987, Science.

[37]  J Deisenhofer,et al.  Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. II. Crystallographic refinement at 1.9 A resolution. , 1974, Journal of molecular biology.

[38]  R. Huber,et al.  Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. Crystal structure determination and stereochemistry of the contact region. , 1973, Journal of molecular biology.